from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0557/mgtA

LFCtreatmentdescriptionclass of inhibitor

-0.015

Amikacinug/mL Amikacintranslation

-0.936

Cap5-10ug/mL Capreomycintranslation

-0.173

Rox10-50 ug/mL Roxithromycintranslation

-0.909

SM2-5 ug/mL Streptomycintranslation

-0.661

Tet5-10 ug/mL Tetracyclinetranslation

-0.237

Rif0.2-5ug/mL Rifampicintranscription

0.202

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.655

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.204

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.105

CPZ10-50 ug/mL Chlorpromazinerespiration

0.854

Clofazimine10-13 ug/mL Clofaziminerespiration

0.162

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.986

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.124

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.735

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.497

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.200

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.261

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.267

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.436

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.171

KCN5-20 ug/mL Potassium cyaniderespiration

0.486

NaN30.2-2 mM Sodium aziderespiration

-0.086

Nigericin50 uM Nigericinrespiration

0.460

TRC10-150 ug/mL Triclosanrespiration

0.484

TRZ10-25 ug/mL Thioridazinerespiration

3.218

Valinomycin0.5-10 uM Valinomycinrespiration

-0.770

ZnSO42 mM ZnSO4respiration

0.136

menadione6-10 ug/mL Menadionerespiration

-0.056

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.343

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.126

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.348

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.267

NRP_1Non-replicating persistence stage 1dosRassociated

-0.638

Amp0.2mg/mL AmpicillincellWall

-0.198

Cephalexin20-100 ug/mL CephalexincellWall

-0.417

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.978

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.803

EMB10-20 ug/mL EthambutolcellWall

-0.300

Eta12-40 ug/mL EthionamidecellWall

0.004

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.241

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.057

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.244

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.219

BZA0.12 mg/mL BenzamidearomaticAmides

0.713

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.183

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.402

H2O24 mM hydrogen peroxideDNAdamaging

-0.025

Levo10 ug/mL LevofloxacinDNAdamaging

-0.629

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.538

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.030

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.459

UVUV-irradiationDNAdamaging

-1.065

ARP41-4 ug/mL Antitubercular compound ARP4?

0.064

Antimycin12.5-50 ug/mL Antimycin A?

-0.377

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.017

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.127

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.718

PA8240.2-2 ug/mL PA-824?

0.213

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.528

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.533

Verapamil50 uM Verapamil?

-0.127

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.365

methoxatin10-20 ug/mL Methoxatin?